Skip to content
Review

Decoding Cardiovascular Disease Through Spatial Proteomics.

Jul 2026 · Circulation Research · Vol 139 4, pp. e327475 · 0 citations · 156 references
Medicine

TL;DR

An integrated workflow in which untargeted, whole-tissue mapping of thousands of proteins is first used to unbiasedly discover spatial patterns and generate hypotheses by identifying candidate regions and proteins of interest, followed by hypothesis testing and validation using high-precision region-of-interest-based proteomics and targeted protein imaging is proposed.

Abstract

Cardiovascular function is tightly linked to tissue architectures, where the spatial organization of cells, extracellular matrix (ECM), vascular networks, and remodeling processes governs physiological performance and disease progression. Spatial proteomics has, therefore, emerged as a powerful framework for understanding cardiovascular biology and cardiovascular disease mechanisms by revealing spatially organized protein regulation across various physiological and pathological states. In this review, we focus on spatial proteomics strategies most relevant to cardiovascular research and discuss their applications through representative examples. These approaches can be broadly categorized into region-of-interest-based methods, which enable precise characterization of localized cellular heterogeneity, and tissue mapping strategies, which capture spatial organization and biologically relevant region-to-region variability across larger tissue domains. In addition, spatial proteomics platforms differ in their capacity for targeted or untargeted protein analysis, influencing both proteome coverage and their suitability for hypothesis-driven versus discovery-based studies. We evaluate the strengths and limitations of state-of-the-art technologies across 3 key parameters, molecular depth, spatial coverage, and spatial resolution, and discuss how these parameters shape study design and biological understanding. Building on these considerations, we argue that a comprehensive understanding of cardiovascular tissue biology requires spatial proteomics strategies that capture both localized molecular details and spatial organization across large tissue areas, as neither alone is sufficient to explain complex tissue behavior. We propose an integrated workflow in which untargeted, whole-tissue mapping of thousands of proteins is first used to unbiasedly discover spatial patterns and generate hypotheses by identifying candidate regions and proteins of interest, followed by hypothesis testing and validation using high-precision region-of-interest-based proteomics and targeted protein imaging. This sequential framework leverages the complementary strengths of tissue-wide mapping and region-of-interest-based approaches to provide multiscale, mechanistic insights into spatially organized disease processes. Finally, we discuss emerging directions that are poised to expand the scope of spatial proteomics in cardiovascular research.

View source

Similar papers

Review Open access Sep 2026

Spatial proteomics: technical evolution and applications in cancer research

Spatial proteomics is reshaping tissue-based cancer research by linking protein expression to cellular identity, tissue architecture and clinical behavior. Conventional proteomics has provided powerful tools for protein identification and quantification, but most bulk workflows erase the spatial relationships that defi...

Xiao-Xiao Tian, Di Huang, Jia-Xiang Hu · 0 citations
Open access Aug 2026

Proteome modulation by opposite inotropic drugs in human engineered cardiac tissue revealed by topology-driven cross-modal integration

Engineered heart tissues (EHTs) represent an innovative platform enabling physiologically relevant in vitro evaluation of drug-induced cardiac responses. While functional characterization remains central to EHTs, molecular profiling is increasingly used to elucidate mechanisms underlying drug-induced phenotypes. Proteo...

D. Staykova, D. Snippert, Hans J. C. T. Wessels et al. · 0 citations
Review Open access Sep 2026

Emerging Technologies in Cardiovascular Disease Modeling: Bridging Basic Science and Clinical Translation

Cardiovascular diseases (CVDs) remain the leading cause of death worldwide, yet therapeutic development is limited by experimental models that incompletely recapitulate human physiology, disease heterogeneity, and treatment responses. Emerging human-relevant models, including patient-derived induced pluripotent stem ce...

R. S. Angom, Sophie K. Ashbrook, Carter Magnano et al. · 0 citations
Review Open access Sep 2026

Multiscale interactions in cardiovascular homeostasis and remodeling: from molecular coupling to organelle and multicellular networks

This Editorial highlights hierarchical mitochondrial quality control and defines directionality, spatial context, temporal order, and flux within these interactions will be essential for converting descriptive interaction maps into causal physiology and selective therapies.

Motohiro Nishida · 0 citations
Review Open access Sep 2026

Integrative multi-omics and network biology in cardiovascular disease: a systems-level framework for translational discovery

This review provides a comprehensive, systems-level framework for translational discovery in cardiovascular disease, synthesizing advances in multi-omics technologies, network biology, artificial intelligence, and bioinformatics applied to conditions including thoracic aortic aneurysm, heart failure, valvular disease,...

V. Brecher, V. Androutsopoulou, S. Sicouri et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.